Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 3
2007 4
2008 3
2009 1
2010 1
2011 7
2012 8
2013 8
2014 12
2015 10
2016 16
2017 8
2018 20
2019 29
2020 80
2021 118
2022 161
2023 120
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

560 results

Results by year

Filters applied: . Clear all
Page 1
2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout.
Lorenzo JPP, Sollano MHMZ, Salido EO, Li-Yu J, Tankeh-Torres SA, Wulansari Manuaba IAR, Rahman MM, Paul BJ, Mok MY, De Silva M, Padhan P, Lim AL, Marcial M, Vicera JJ, Haq SA, Salman S, Liyanage CK, Keen HI, Yew Kuang C, Wei JC, Hellmi RY, Chan CE Jr, Louthrenoo W. Lorenzo JPP, et al. Among authors: wei jc. Int J Rheum Dis. 2022 Jan;25(1):7-20. doi: 10.1111/1756-185X.14266. Epub 2021 Dec 20. Int J Rheum Dis. 2022. PMID: 34931463
Epidemiological Study of the Effectiveness of Paxlovid.
Chen HY, Chang R, Wei JC. Chen HY, et al. Among authors: wei jc. Clin Infect Dis. 2022 Dec 19;75(12):2278. doi: 10.1093/cid/ciac664. Clin Infect Dis. 2022. PMID: 35975644 No abstract available.
Optimal composite measures for psoriatic arthritis.
Huang JX, Lee YH, Wei JC. Huang JX, et al. Among authors: wei jc. Int J Rheum Dis. 2023 Oct;26(10):1897-1898. doi: 10.1111/1756-185X.14829. Int J Rheum Dis. 2023. PMID: 37807619 No abstract available.
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W).
Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS; COAST-V and COAST-W Study Groups. Dougados M, et al. Among authors: wei jc. Ann Rheum Dis. 2020 Feb;79(2):176-185. doi: 10.1136/annrheumdis-2019-216118. Epub 2019 Nov 4. Ann Rheum Dis. 2020. PMID: 31685553 Free PMC article. Clinical Trial.
Tofacitinib for sarcoidosis, a new potential treatment.
Xu Q, Huang ZS, Liu QP, Wei JC. Xu Q, et al. Among authors: wei jc. Int J Rheum Dis. 2022 Nov;25(11):1217-1219. doi: 10.1111/1756-185X.14441. Int J Rheum Dis. 2022. PMID: 36320145 No abstract available.
560 results